← Open Payments lookup

KEVIN SUMMERS: Open Payments

NPI 1477103851 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$533 in 12 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $533

Food & beverage: $533
CompanyPaymentsAmount
TG Therapeutics, Inc.2$216
AstraZeneca Pharmaceuticals LP2$130
Janssen Biotech, Inc.2$46
Alnylam Pharmaceuticals Inc.1$34
ARGENX US, INC.1$24
Alexion Pharmaceuticals, Inc.1$23
Biogen, Inc.1$23
Genentech USA, Inc.1$20
GlaxoSmithKline, LLC.1$18

Products named: BRIUMVI, TEZSPIRE, TREMFYA, ONPATTRO, SAPHNELO, VYVGART HYTRULO, ULTOMIRIS, TYSABRI.

Industry payments across TX — which companies pay providers there.